You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. Upregulation of miR-183 inhibits the invasion and migration of endometrial stromal cells in endometriosis patients by downregulating Ezrin
- 2. Accord Healthcare receives approval for Hetronifly® (Serplulimab), from the Medicines and Healthcare Regulatory Agency (MHRA) for first-line treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
- 3. Your CT scan could reveal a hidden heart risk—and AI just learned how to find it
- 4. Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer—an open-label phase 2 randomized controlled trial
- 5. Machine learning-based preoperative prediction of perioperative venous thromboembolism in Chinese lung cancer patients: a retrospective cohort study
- 6. Vaccine therapies for glioma: clinical frontiers and potential breakthrough
- 7. Rare metastasis of the urinary bladder from esophageal squamous cell carcinoma: a case report
- 8. CHMP6 as a novel prognostic biomarker in bladder cancer: insights from a comprehensive cell death-related gene risk model
- 9. Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants
- 10. Exploration of the role and mechanism of Rhizoma Paridis total saponins in osteosarcoma based on SPI1/LCN2-mediated ferroptosis
Last updated at 19:41 GMT
Hot News Makers
Health/Pharma Companies
- 163119.77
- 20036.22
- 19955.28
- 17253.72
- 14264.86
- 13794.82
- 13782.54
- 12679.87
- 8327.87
- 7975.60
Drugs, Treatments, Trials
- 239764.18
- 65919.18
- 5914.83
- 4956.93
- 3588.73
- 2943.05
- 2868.70
- 2336.14
- 2013.42
- 1944.29
Last updated at 19:10 GMT
